Riboflavin in Brown-Vialetto-Van Laere Syndrome

Investigators at Great Ormond Street Hospital, London, UK, and multiple centers internationally report the response to high-dose oral riboflavin therapy in 18 patients from 13 families with mutations in SLC5ZA2, encoding riboflavin transporter RTVT2, a new causative gene for Brown-Vialetto-Van Laere...

Full description

Saved in:
Bibliographic Details
Main Authors: J Gordon Millichap, John J Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 2014-03-01
Series:Pediatric Neurology Briefs
Subjects:
Online Access:https://www.pediatricneurologybriefs.com/articles/189
Tags: Add Tag
No Tags, Be the first to tag this record!